Another study demonstrated that arctigenin exhibits anti-metastatic effects on breast cancer cell lines by inhibiting MMP-9 and uPA by targeting the Akt, NF-κB, and MAPK signaling pathways (Maxwell et al., 2017). Here, AKT1 is linked to breast carcinoma.